作者
Mototsugu Tanaka,Mutsuhiro Ikuma,Wataru Asakura,Yasuhiro Fujiwara
摘要
Clinical Pharmacology & TherapeuticsEarly View Perspective The PMDA Perspectives on New Oral Prolyl Hydroxylase Domain Enzyme Inhibitors for Renal Anemia Mototsugu Tanaka, Corresponding Author motanaka-tky@umin.ac.jp Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan Correspondence: Mototsugu Tanaka (motanaka-tky@umin.ac.jp)Search for more papers by this authorMutsuhiro Ikuma, Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanSearch for more papers by this authorWataru Asakura, Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanSearch for more papers by this authorYasuhiro Fujiwara, Chief Executive, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanSearch for more papers by this author Mototsugu Tanaka, Corresponding Author motanaka-tky@umin.ac.jp Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan Correspondence: Mototsugu Tanaka (motanaka-tky@umin.ac.jp)Search for more papers by this authorMutsuhiro Ikuma, Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanSearch for more papers by this authorWataru Asakura, Office of New Drug 1, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanSearch for more papers by this authorYasuhiro Fujiwara, Chief Executive, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanSearch for more papers by this author First published: 16 May 2021 https://doi.org/10.1002/cpt.2275Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat Early ViewOnline Version of Record before inclusion in an issue RelatedInformation